On the prevalence of somatic pathology among patients with mental disorders
- Authors: Mendelevich BD1, Kuklina AM2
 - 
							Affiliations: 
							
- Cabinet of Ministers of the Republic of Tatarstan, Kazan, Russia
 - Naberezhnye-Chelny Psychoneurological Dispensary of the Republican Clinical Psychiatric Hospital, Naberezhnye-Chelny, Russia
 
 - Issue: Vol 93, No 3 (2012)
 - Pages: 532-534
 - Section: Epidemiology and healthcare management
 - URL: https://journal-vniispk.ru/kazanmedj/article/view/1887
 - DOI: https://doi.org/10.17816/KMJ1887
 - ID: 1887
 
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
B D Mendelevich
Cabinet of Ministers of the Republic of Tatarstan, Kazan, Russia
A M Kuklina
Naberezhnye-Chelny Psychoneurological Dispensary of the Republican Clinical Psychiatric Hospital, Naberezhnye-Chelny, Russia
														Email: dr.kuklina@mail.ru
				                					                																			                												                														
References
- Незнанов Н.Г., Мартынихин И.А., Соколян Н.А., Танянский Д.А. Частота и характер метаболических нарушений у больных шизофренией // Обозр. психиат. и мед. психол. им. В.М. Бехтерева. - 2009. - №2. - C. 17-20.
 - Barnett A.H., Mackin P., Chaudhry I. et al. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia // J. Psychopharmacol. - 2007. - Vol. 4 - P. 357-373.
 - Carney C.P., Jones L., Woolson R.F. Medical comorbidity in women and men with schizophrenia: a population-based controlled study // Department of Internal Medicine: USA. - 2006. - Vol. 21. - P. 1133-1137.
 - Consensus development conference on antipsychotic drugs and obesity and diabetes // American Diabetes Association, American Psychiatric Association. - 2004. - Vol. 27. - P. 596-601.
 - Druss B.G., Radford W.D., Rosenheck R.A. et al. Quality of medical care and excess mortality in older patients with mental disorders // Arch. Gen. Psychiatry - 2001. - Vol. 58. - P. 565-572.
 - Jeste D.V., Gladsjo J.A., Lindamer L.A., Lacro J.P. Medical comorbidity in schizophrenia // Schizophr. Bull. - 1996. - Vol. 22. - P. 413-430.
 - Osby U., Correia N., Brandt L. et al. Mortality and causes of death in schizophrenia in Stockholm county, Sweden // Psych. Res. - 2000. - Vol. 45. - P. 21-28.
 - McEvoy J., Meyer J., Goff D. et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III // Schizophr. Res. - 2005. - Vol. 80. - P. 19-32.
 - Parks J., Svendsen D., Foti M.E. et al. Morbidity and mortalityin people with serious mental illness: technical report / National Association of State Mental Health Program Directors. - 2006. - 1482 p.
 
Supplementary files
				
			
					
						
				

